Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AgelessRx vs FitRx

By GLP-1 ScorecardUpdated

AgelessRx
Site position #17

Higher grade

FitRx
Site position #313

Lower grade

Score comparison

AgelessRx has the higher recorded score — 84.3/100 to 62/100.

AgelessRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Conventional and microdose GLP-1 programs with continuing care; branded prescriptions involve a separate pharmacy payment.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueAgelessRx +27
90
63
Dose & formulationAgelessRx +15
80
65
Clinical oversightAgelessRx +28
83
55
Labs & monitoringAgelessRx +29
82
53
FulfillmentFitRx +4
84
88
Contract termsAgelessRx +38
85
47
AgelessRx · top barFitRx · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricAgelessRxFitRx
WeighScore84.3/10062/100
GradeBC
Site position#17#313
SemaglutideNot verified (current medication-specific quote required)$151/mo (quarterly plan, compounded)
TirzepatideMicrodose: $109 first month, then $318 every 2 months ($159/mo); full-dose quote requiredNot disclosed
CoverageAdvertises US service; confirm treatment-specific state availabilityAll 50 states
Brand-name accessYesYes
Oral / sublingualYesNot confirmed
AgelessRx

Site position #17 · B

Strengths

  • Conventional and lower-dose GLP-1 programs advertised
  • Wegovy pens and oral-tablet consultations advertised
  • Continuing messaging and check-ins advertised

What to consider

  • Conventional medication-specific monthly quotes not verified
  • Microdose introduction renews as a two-month charge
  • Branded medication has a separate pharmacy bill
  • Treatment-specific state eligibility and assigned dispenser need confirmation
FitRx

Site position #313 · C

FDAWarning letter issued to FitRX, LLC dba FitRx in February 2026. See the FDA warning-letter database.

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • LegitScript certified
  • All 50 states + DC coverage
  • Compounded semaglutide from $151/mo quarterly for uninsured patients

What to consider

  • Insurance coordination may not work for all plans
  • Broader platform (birth control, mental health, hair loss, ED, skincare, primary care)
  • Compounded option is semaglutide only — no compounded tirzepatide
  • FDA issued FitRX, LLC dba FitRx a warning letter in February 2026; the letter is public in FDA's warning-letter database

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard